New England Biolabs UK Ltd CST - Cell Signaling Technology Biohelix Corp
Search:
Product CatalogueNew from New England Biolabs...Special OffersTechnical ResourcesContact UsMy Account
home > Product Catalogue > New England Biolabs > Nucleic Acids > LITMUS Transcription Vectors > LITMUS 28i Vector
LITMUS 28i Vector
Catalog # Size Concentration Price(£) Qty
N3528S 20 μg 500 μg/ml 63.00
Download:MSDS PDF


  • Extensive set of restriction sites in polylinker, many with unique 4-base overhangs
  • Blue/white section
  • Opposing T7promoters for making RNA transcripts in either direction or double-stranded RNA using the HiScribe™ T7 In Vitro Transcription Kit (NEB #E2030)
Description:
LITMUS 28i is a multi-purpose cloning/in vitro transcription phagemid vector. The molecule is a small, double-stranded circle 2,823 base pairs in length (molecular weight�=1.8 x 106 daltons).

Source:
LITMUS 28i is isolated from E. coli ER2738 by a standard plasmid purification procedure.

Advantages:
  • Small (< 3 kb), high copy number.
  • Ampicillin resistance.
  • Single-stranded (M13) DNA replication origin.
  • Compatible with pUC/M13 sequencing primers as well as LITMUS sequencing primers.
Concentration:
500 μg/ml


Storage Conditions


Storage Conditions:
10 mM Tris-HCl
1 mM EDTA
pH 8.0 @ 25°C

Storage Temperature:
-20°C


Notes


General notes:
  1. Appropriate strains of E. coli containing the LITMUS 28i plasmid form blue colonies on X-gal plates; when a fragment is inserted in the polylinker, the colonies are white. Blue/white selection is best achieved by plating on a rich media (e.g. LB) supplemented with X-gal (40��g/ml) and IPTG (0.1 mM).

FAQs


  1. How homogeneous is the DNA/ how much is supercoiled?
  2. Are the plasmids cesium purified?
  3. What primers should I use to sequence an insert (pUC19, pNEB193, LITMUS)?


Enzymes in parentheses ( ) leave 3' extension and should not be used for template linearization.




Companion Products


HiScribe™ T7 In Vitro Transcription Kit
LITMUS 28/38 Forward Sequencing Primer (21-mer)
LITMUS 28/38 Reverse Sequencing Primer (21-mer)
LITMUS 38i Vector


Legal


Patents:
New England Biolabs, Inc.: U.S. 5,691,140

Research Use Assurance:
The Buyer/User has a non-exclusive license to use this vector for RESEARCH PURPOSES ONLY.* Commercial use of the LITMUS Vectors may require a license from New England Biolabs.

*Use of this vector for RNA interference may require a license�from the Carnegie Institution of Washington. For further information, contact the Director of Administration and Finance at the Carnegie Institute of Washington at 1530 P Street, N.W., Washington�D.C., 20005-1910. Tel: 202-939-1118.